Spinal Anesthesia. local anaesthetics
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants including major eligibility criteria: The patients aged from 40-70 years Participants excluding major eligibility criteria: Patients with history Neurologic disease and Neuromuscular; Diabetes Mellitus; Patients with Neuropathy Peripheral; Infection in site of injection; Sensitivity to Local Anesthesia; Patients with Vomiting and Nausea before surgery or receiving 48 hours before surgery Anti Vomiting and Nausea; Women in period of mense
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of Vomiting and Nausea. Timepoint: Incidence of Nausea and Vomiting were studied in patients within 24 hours after injection of Atropine: Hourly up to 6 hours, Then 6 hours later and Finally 12 hours later. Method of measurement: With checklist: Mild; Moderate; Severe. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart Rate. Timepoint: 3,5,10,15 Minutes after Spinal Anesthesia with receiving Atropin Interathecal. Method of measurement: Heart Rate per minute.;Blood Pressure. Timepoint: 3,5,10,15 Minutes after Spinal Anesthesia with receiving Atropin Intrathecal. Method of measurement: Blood volume pump by heart.;With out pain period. Timepoint: Intrathecal Morphine-Induced Analgesia was studied in 2 hours intervals for 12 hours after injection. Method of measurement: With checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Qazvin University of Medical Sciences